Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Abroad (travel likely)RecruitingPHASE3
Conditions
Common Warts (Verruca Vulgaris) · Common Warts · Human Papilloma Virus (HPV) · Warts
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Florida Center for Dermatology, P.A., Saint Augustine, Florida, United States
The Indiana Clinical Trials Center, PC, Plainfield, Indiana, United States
Optima Research Boardman, Boardman, Ohio, United States
Texas Dermatology, San Antonio, Texas, United States
Study leads
Adelaide A Hebert, MD
Principal Investigator
UTHealth McGovern Medical School - Houston